A parliamentary committee in India has recommended a complete ban on the purchase of existing domestic pharmaceutical firms by foreign drug companies as not being in the public interest. One reason for the ban, according to the committee panel: a threat to India's generic drug business. India permits foreign investment in existing pharmaceutical companies only with approval of the Foreign Investment Promotion Board.

Related Summaries